Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Goodwill & Intangibles (2020 - 2026)

PROCEPT BioRobotics has reported Goodwill & Intangibles over the past 7 years, most recently at $640000.0 for Q1 2026.

  • Quarterly Goodwill & Intangibles fell 25.93% to $640000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $640000.0 through Mar 2026, down 25.93% year-over-year, with the annual reading at $709000.0 for FY2025, 23.93% down from the prior year.
  • Goodwill & Intangibles was $640000.0 for Q1 2026 at PROCEPT BioRobotics, down from $709000.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $1.7 million in Q1 2022 and troughed at $640000.0 in Q1 2026.
  • The 5-year median for Goodwill & Intangibles is $1.1 million (2024), against an average of $1.1 million.
  • Year-over-year, Goodwill & Intangibles dropped 15.02% in 2022 and then dropped 27.3% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $1.5 million in 2022, then fell by 18.48% to $1.2 million in 2023, then fell by 22.59% to $932000.0 in 2024, then fell by 23.93% to $709000.0 in 2025, then decreased by 9.73% to $640000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Goodwill & Intangibles are $640000.0 (Q1 2026), $709000.0 (Q4 2025), and $727000.0 (Q3 2025).